Insights

Loading spinner
Gathering insights about Olaris, Inc

Olaris, Inc Tech Stack

Olaris, Inc uses 8 technology products and services including Open Graph, MySQL, Module Federation, and more. Explore Olaris, Inc's tech stack below.

  • Open Graph
    Content Management System
  • MySQL
    Database
  • Module Federation
    Development
  • Google Cloud
    Infrastructure As A Service
  • Sentry
    Issue Trackers
  • PHP
    Programming Languages
  • Onsen UI
    Software Development
  • YouTube
    Video Players

Olaris, Inc's Email Address Formats

Olaris, Inc uses at least 2 format(s):
Olaris, Inc Email FormatsExamplePercentage
FLast@olaristherapeutics.comJDoe@olaristherapeutics.com
100%
FLast@myolaris.comJDoe@myolaris.com
100%

Frequently Asked Questions

Where is Olaris, Inc's headquarters located?

Minus sign iconPlus sign icon
Olaris, Inc's main headquarters is located at 175 Crossing Boulevard, Suite 410. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Olaris, Inc's phone number?

Minus sign iconPlus sign icon
You can contact Olaris, Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Olaris, Inc's official website and social media links?

Minus sign iconPlus sign icon
Olaris, Inc's official website is myolaris.com and has social profiles on LinkedInCrunchbase.

What is Olaris, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Olaris, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Olaris, Inc have currently?

Minus sign iconPlus sign icon
As of December 2025, Olaris, Inc has approximately 15 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Business Officer: R. H.Chief Operating Officer & Chief Financial Officer: T. B.Associate Director Of Nmr Technology: R. H.. Explore Olaris, Inc's employee directory with LeadIQ.

What industry does Olaris, Inc belong to?

Minus sign iconPlus sign icon
Olaris, Inc operates in the Biotechnology Research industry.

What technology does Olaris, Inc use?

Minus sign iconPlus sign icon
Olaris, Inc's tech stack includes Open GraphMySQLModule FederationGoogle CloudSentryPHPOnsen UIYouTube.

What is Olaris, Inc's email format?

Minus sign iconPlus sign icon
Olaris, Inc's email format typically follows the pattern of FLast@olaristherapeutics.com. Find more Olaris, Inc email formats with LeadIQ.

When was Olaris, Inc founded?

Minus sign iconPlus sign icon
Olaris, Inc was founded in 2013.

Olaris, Inc

Biotechnology ResearchMassachusetts, United States11-50 Employees

Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine.

Section iconCompany Overview

Headquarters
175 Crossing Boulevard, Suite 410
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Olaris, Inc's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Olaris, Inc's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.